What is Sigray?
Sigray specializes in the development and manufacturing of laboratory x-ray systems that emulate synchrotron-like capabilities. Their sophisticated product portfolio includes x-ray absorption spectroscopy systems, x-ray fluorescence microscopy, and 3D x-ray microscopes. These instruments are crucial for detailed analysis of microstructure, chemistry, and composition, serving a diverse clientele across materials science, semiconductor industries, life sciences, and pharmaceuticals. Sigray's patented technologies are instrumental in achieving high-resolution imaging and precise elemental mapping, positioning the company as a leader in the specialized field of x-ray instrumentation.
How much funding has Sigray raised?
Sigray has raised a total of $1.2M across 2 funding rounds:
Debt
$350K
Debt
$882K
Debt (2020): $350K with participation from PPP
Debt (2021): $882K led by PPP
Key Investors in Sigray
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Sigray?
The recent major strategic investment signals a period of accelerated growth and development for Sigray. This capital infusion is expected to fuel further innovation in their x-ray technology, potentially expanding their product offerings and market reach. The company's focus on enabling high-resolution analysis for critical research sectors suggests a trajectory aimed at solidifying its position as an indispensable partner for scientific discovery and industrial advancement. Future developments may include enhanced imaging capabilities and broader applications in emerging scientific fields.
See full Sigray company page
